Ball Bryan's Form 4 filing
Whitehawk Therapeutics, Inc. (WHWK) · filed Apr 15, 2026
- Accession no.
- 0001766522-26-000011
- Filed
- Apr 15, 2026
- Trade date
- Apr 13-14, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market sales total $427.9K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Ball BryanCIK 0001766522 | Officer (See remarks) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 13, 2026 | Common Stock | SSaleDisposed | −26,389 | $3.46 | −$91,305.94 | 489,566 | Direct | |
| Apr 14, 2026 | Common Stock | SSaleDisposed | −92,460 | $3.64 | −$336,554.4 | 397,106 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.
Remarks
Chief Technical Operations Officer and SVP, Manufacturing Operations